Enhanced immunostimulatory activity of oligodeoxynucleotides by Y-shape formation

Immunology

Volumn 124, Issue 2, 2008, Pages 247-255

  Nishikawa, Makiya ^a   Matono, Mitsuhiro ^a   Rattanakiat, Sakulrat ^a   Matsuoka, Nao ^a   Takakura, Yoshinobu ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

CpG motif; Immunostimulatory activity; Oligodeoxynucleotides; Toll like receptor 9; Y shape formation

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; CYTOKINE; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; OLIGODEOXYNUCLEOTIDE DERIVATIVE; POLYMYXIN B; TUMOR NECROSIS FACTOR ALPHA;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CELL TRANSPORT; CYTOKINE RELEASE; DRUG RESEARCH; DRUG STABILITY; IMMUNOSTIMULATION; MACROPHAGE; MOUSE; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN STRUCTURE; STRUCTURE ACTIVITY RELATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BASE SEQUENCE; CELL LINE; CHEMISTRY, PHYSICAL; CPG ISLANDS; CULTURE MEDIA, CONDITIONED; CYTOKINES; MACROPHAGES; MICE; MOLECULAR SEQUENCE DATA; OLIGODEOXYRIBONUCLEOTIDES; STRUCTURE-ACTIVITY RELATIONSHIP; TOLL-LIKE RECEPTOR 9;

EID: 43749114235     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2007.02762.x     Document Type: Article

References (32)

1. Krieg AM. CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 2002 20 : 709 60.
2. Hemmi H, Takeuchi O, Kawai T et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000 408 : 740 5.
3. Tokunaga T, Yamamoto H, Shimada S et al. Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity. J Natl Cancer Inst 1984 72 : 955 62.
4. Hartmann G, Weiner GJ, Krieg AM. CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells. Proc Natl Acad Sci U S A 1999 96 : 9305 10.
5. Klinman DM, Yi AK, Beaucage SL, Conover J, Krieg AM. CpG motifs present in bacterial DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon γ. Proc Natl Acad Sci U S A 1996 93 : 2879 83.
6. Sparwasser T, Miethke T, Lipford G, Erdmann A, Hacker H, Heeg K, Wagner H. Macrophages sense pathogens via DNA motifs: induction of tumor necrosis factor-α-mediated shock. Eur J Immunol 1997 27 : 1671 9.
7. Sato Y, Roman M, Tighe H et al. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 1996 273 : 352 4.
8. Dalpke A, Zimmermann S, Heeg K. Immunopharmacology of CpG DNA. Biol Chem 2002 383 : 1491 500.
9. Kandimalla ER, Yu D, Agrawal S. Towards optimal design of second-generation immunomodulatory oligonucleotides. Curr Opin Mol Ther 2002 4 : 122 9.
10. Yi AK, Chang M, Peckham DW, Krieg AM, Ashman RF. CpG oligodeoxyribonucleotides rescue mature spleen B cells from spontaneous apoptosis and promote cell cycle entry. J Immunol 1998 160 : 5898 906.
11. Rankin R, Pontarollo R, Ioannou X, Krieg AM, Hecker R, Babiuk LA, van Drunen Little-van den Hurk S. CpG motif identification for veterinary and laboratory species demonstrates that sequence recognition is highly conserved. Antisense Nucleic Acid Drug Dev 2001 11 : 333 40.
12. Dalpke AH, Zimmermann S, Albrecht I, Heeg K. Phosphodiester CpG oligonucleotides as adjuvants: polyguanosine runs enhance cellular uptake and improve immunostimulative activity of phosphodiester CpG oligonucleotides in vitro and in vivo. Immunology 2002 106 : 102 12.
13. Wu CC, Lee J, Raz E, Corr M, Carson DA. Necessity of oligonucleotide aggregation for Toll-like receptor 9 activation. J Biol Chem 2004 279 : 33071 8.
14. Adleman LM. Molecular computation of solutions to combinatorial problems. Science 1994 266 : 1021 4.
15. Sakamoto K, Gouzu H, Komiya K, Kiga D, Yokoyama S, Yokomori T, Hagiya M. Molecular computation by DNA hairpin formation. Science 2000 288 : 1223 6.
16. Yan H, Zhang X, Shen Z, Seeman NC. A robust DNA mechanical device controlled by hybridization topology. Nature 2002 415 : 62 5.
17. Watson KJ, Park SJ, Im JH, Nguyen ST, Mirkin CA. DNA-block copolymer conjugates. J Am Chem Soc 2001 123 : 5592 3.
18. Condon A. Designed DNA molecules: principles and applications of molecular nanotechnology. Nat Rev Genet 2006 7 : 565 75.
19. Rothemund PW. Folding DNA to create nanoscale shapes and patterns. Nature 2006 440 : 297 302.
20. Li Y, Tseng YD, Kwon SY, D'Espaux L, Bunch JS, Mceuen PL, Luo D. Controlled assembly of dendrimer-like DNA. Nat Mater 2004 3 : 38 42.
21. Li Y, Cu YT, Luo D. Multiplexed detection of pathogen DNA with DNA-based fluorescence nanobarcodes. Nat Biotechnol 2005 23 : 885 9.
22. Poste G, Doll J, Hart IR, Fidler IR. In vitro selection of murine B16 melanoma variants with enhanced tissue-invasive properties. Cancer Res 1980 40 : 1636 44.
23. Hyoudou K, Nishikawa M, Umeyama Y, Kobayashi Y, Yamashita F, Hashida M. Inhibition of metastatic tumor growth in mouse lung by repeated administration of polyethylene glycol-conjugated catalase: quantitative analysis with firefly luciferase-expression melanoma cells. Clin Cancer Res 2004 10 : 7685 91.
24. Manzel L, Macfarlane DE. Lack of immune stimulation by immobilized CpG-oligonucleotide. Antisense Nucleic Acid Drug Dev 1999 9 : 459 64.
25. Kandimalla ER, Bhagat L, Cong YP, Pandey RK, Yu D, Zhao Q, Agrawal Q. Secondary structures in CpG oligonucleotides affect immunostimulatory activity. Biochem Biophys Res Commun 2003 306 : 948 53.
26. Cong YP, Song SS, Bhagat L, Pandey RK, Yu D, Kandimalla ER, Agrawal S. Self-stabilized CpG DNAs optimally activate human B cells and plasmacytoid dendritic cells. Biochem Biophys Res Commun 2003 310 : 1133 9.
27. Shimosato T, Kimura T, Tohno M et al. Strong immunostimulatory activity of AT-oligodeoxynucleotide requires a six-base loop with a self-stabilized 5′-C...G-3′ stem structure. Cell Microbiol 2006 8 : 485 95.
28. Latz E, Schoenemeyer A, Visintin A et al. TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat Immunol 2004 5 : 190 8.
29. Roberts TL, Dunn JA, Terry TD, Jennings MP, Hume DA, Sweet MJ, Stacey KJ. Differences in macrophage activation by bacterial DNA and CpG-containing oligonucleotides. J Immunol 2005 175 : 3569 76.
30. Kandimalla ER, Bhagat L, Yu D, Cong Y, Tang J, Agrawal S. Conjugation of ligands at the 5′-end of CpG DNA affects immunostimulatory activity. Bioconjug Chem 2002 13 : 966 74.
31. Krieg AM. Therapeutic potential of Toll-like receptor 9 activation. Nat Rev Drug Discov 2006 5 : 471 84.
32. Henry SP, Giclas PC, Leeds J, Pangburn M, Auletta C, Levin AA, Kornbrust DJ. Activation of the alternative pathway of complement by a phosphorothioate oligonucleotide: potential mechanism of action. J Pharmacol Exp Ther 1997 281 : 810 6.